Export financials
American Well Corporation (AMWL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.

American Well Corporation Balance Sheet 2025-2011 | AMWL
Brief balance sheet overview of American Well Corporation
Balance sheet changes are traced across five available annual reports between 2021 and 2025.
Assets finished at $323.8 million versus $1.4 billion initially, losing -77.6%. The balance sheet contracted.
Liabilities grew faster than assets: -58.9% versus -77.6%. A substantial part of expansion was externally funded.
Equity funds 72.8% of assets versus 87.2% initially. This creates a conservative balance sheet structure.
Net debt moved below zero to -$177.8 million, reflecting surplus cash over debt.
The cash reserve occupies 56.3% of the balance sheet, previously 51.6%. It is one marker of short-term resilience.
The balance sheet carries negative retained earnings of -$2.1 billion. The figure may result from accumulated losses or an active capital return policy.
Conclusion
American Well Corporation's financial structure is not clear-cut. Asset scale alone does not resolve questions about how those assets are funded.
Annual Balance Sheet American Well Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-178 M | -220 M | -360 M | -524 M | -730 M | -934 M | -124 M | -48 M | - | - | - | - | - | - | - |
Long Term Debt |
892 K | 4.51 M | 8.21 M | 11.8 M | 14.7 M | 1.3 M | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
3.63 M | 3.69 M | 3.58 M | 3.06 M | 1.92 M | 6.36 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
2.78 M | 8.46 M | 15.7 M | 19.6 M | 43.3 M | 9.47 M | 674 M | 606 M | - | - | - | - | - | - | - |
Total Current Liabilities |
73.2 M | 111 M | 93.8 M | 114 M | 142 M | 121 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
76 M | 120 M | 110 M | 134 M | 185 M | 130 M | 781 M | 694 M | - | - | - | - | - | - | - |
Deferred Revenue |
22.6 M | 53.2 M | 46.4 M | 49.5 M | 68.8 M | 66.7 M | 66.5 M | 64.1 M | - | - | - | - | - | - | - |
Retained Earnings |
-2.06 B | -1.97 B | -1.76 B | -1.08 B | -811 M | -582 M | -358 M | -271 M | - | - | - | - | - | - | - |
Total Assets |
324 M | 436 M | 590 M | 1.22 B | 1.45 B | 1.38 B | 500 M | 489 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
182 M | 228 M | 372 M | 539 M | 746 M | 942 M | 138 M | 54.1 M | - | - | - | - | - | - | - |
Book Value |
248 M | 316 M | 480 M | 1.08 B | 1.26 B | 1.25 B | -281 M | -204 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
236 M | 305 M | 464 M | 1.06 B | 1.24 B | 1.22 B | -281 M | -204 M | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet American Well Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 892 K | 1.78 M | 2.69 M | 3.57 M | 4.51 M | 5.44 M | 6.36 M | 7.29 M | 8.21 M | 9.09 M | 10 M | 10.8 M | 11.8 M | 12.2 M | 12.8 M | 13.7 M | 14.7 M | 15 M | 776 K | 970 K | 1.3 M | 3.06 M | 1.3 M | 1.3 M | 7.16 M | 7.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
1.34 M | 1.61 M | 2.07 M | 2.78 M | 5.58 M | 6.17 M | 6.97 M | 8.46 M | 10.8 M | 12.1 M | 16.6 M | 15.7 M | 16.6 M | 18.2 M | 20.6 M | 19.6 M | 21.8 M | 21.3 M | 24.2 M | 43.3 M | 59.6 M | 8.33 M | 8.47 M | 9.47 M | 10.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
84 M | 92.9 M | 85.8 M | 76 M | 92.1 M | 94.1 M | 114 M | 120 M | 133 M | 130 M | 125 M | 110 M | 115 M | 128 M | 136 M | 134 M | 127 M | 138 M | 153 M | 185 M | 187 M | 99.7 M | 107 M | 130 M | 117 M | 130 M | 130 M | 125 M | 125 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
20.7 M | 26.2 M | 29.7 M | 22.6 M | 29.5 M | 41.1 M | 57.4 M | 53.2 M | 62.5 M | 64.3 M | 59.1 M | 46.4 M | 53.1 M | 60.2 M | 65.6 M | 49.5 M | 50.2 M | 64 M | 68.8 M | 68.8 M | 60.9 M | 57.8 M | 63.2 M | 66.7 M | 54.3 M | 66.7 M | 66.7 M | 66.5 M | 66.5 M | - | - | 64.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-2.09 B | -2.08 B | -2.07 B | -2.06 B | -2.04 B | -2 B | -1.98 B | -1.97 B | -1.92 B | -1.88 B | -1.83 B | -1.76 B | -1.71 B | -1.57 B | -1.48 B | -1.08 B | -1.02 B | -950 M | -881 M | -811 M | -762 M | -709 M | -669 M | -582 M | -532 M | -582 M | -582 M | -358 M | -358 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
309 M | 327 M | 326 M | 324 M | 359 M | 389 M | 419 M | 436 M | 483 M | 508 M | 548 M | 590 M | 635 M | 772 M | 851 M | 1.22 B | 1.23 B | 1.3 B | 1.36 B | 1.45 B | 1.48 B | 1.29 B | 1.32 B | 1.38 B | 1.41 B | 1.38 B | 1.38 B | 500 M | 500 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
182 M | 197 M | 180 M | 183 M | 202 M | 220 M | 223 M | 229 M | 245 M | 278 M | 309 M | 373 M | 320 M | 162 M | 114 M | 539 M | 333 M | 258 M | 178 M | 747 M | 791 M | 976 M | 897 M | 943 M | 958 M | 942 M | 942 M | 138 M | 138 M | - | - | 48 M | - | - | - | 95.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
225 M | 234 M | 240 M | 248 M | 267 M | 295 M | 306 M | 316 M | 350 M | 378 M | 423 M | 480 M | 520 M | 644 M | 714 M | 1.08 B | 1.1 B | 1.16 B | 1.21 B | 1.26 B | 1.3 B | 1.19 B | 1.22 B | 1.25 B | 1.3 B | 1.25 B | 1.25 B | 375 M | 375 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
225 M | 234 M | 240 M | 248 M | 267 M | 295 M | 306 M | 316 M | 350 M | 378 M | 423 M | 480 M | 520 M | 644 M | 714 M | 1.08 B | 1.1 B | 1.16 B | 1.21 B | 1.26 B | 1.3 B | 1.19 B | 1.22 B | 1.25 B | 1.3 B | 1.22 B | 1.22 B | -307 M | -307 M | -241 M | -223 M | -204 M | - | - | - | -162 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of American Well Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Health information services
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | ||
|
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | ||
|
Change Healthcare
CHNG
|
- | - | $ 9.03 B | ||
|
Covetrus
CVET
|
- | - | $ 2.94 B | ||
|
R1 RCM
RCM
|
- | - | $ 3.81 B | ||
|
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | ||
|
Cerner Corporation
CERN
|
- | - | $ 27.9 B | ||
|
Accolade
ACCD
|
- | 0.29 % | $ 206 M | ||
|
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | ||
|
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | ||
|
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | ||
|
iCAD
ICAD
|
- | - | $ 102 M | ||
|
OptimizeRx Corporation
OPRX
|
$ 6.63 | -5.42 % | $ 123 M | ||
|
HealthStream
HSTM
|
$ 26.18 | 0.15 % | $ 786 M | ||
|
Evolent Health
EVH
|
$ 3.9 | 14.01 % | $ 445 M | ||
|
GoodRx Holdings
GDRX
|
$ 2.91 | -3.64 % | $ 1.04 B | ||
|
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | ||
|
Health Catalyst
HCAT
|
$ 1.32 | 2.33 % | $ 92.3 M | ||
|
HealthEquity
HQY
|
$ 94.7 | -2.75 % | $ 8.16 B | ||
|
Omnicell
OMCL
|
$ 32.36 | -2.47 % | $ 1.49 B | ||
|
Veeva Systems
VEEV
|
$ 266.16 | 1.18 % | $ 43.6 B | ||
|
Progyny
PGNY
|
$ 35.72 | 0.76 % | $ 3.04 B | ||
|
10x Genomics
TXG
|
$ 51.71 | -9.89 % | $ 6.45 B | ||
|
Schrödinger
SDGR
|
$ 22.92 | -12.98 % | $ 1.68 B | ||
|
So-Young International
SY
|
$ 1.66 | -11.97 % | $ 129 M | ||
|
SCWorx Corp.
WORX
|
$ 1.08 | -5.18 % | $ 7.86 M | ||
|
Zhongchao
ZCMD
|
$ 0.78 | -3.79 % | $ 2.67 M | ||
|
Teladoc Health
TDOC
|
$ 7.47 | -4.29 % | $ 1.32 B | ||
|
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | ||
|
Phreesia
PHR
|
$ 11.41 | -4.0 % | $ 682 M | ||
|
Akerna Corp.
KERN
|
- | - | $ 161 M | ||
|
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | ||
|
Premier
PINC
|
- | - | $ 2.33 B | ||
|
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M |